Table 2 Overview of gepants for the treatment of migraine in alphabetical order
From: Therapeutic novelties in migraine: new drugs, new hope?
| Drug | Status |
|---|---|
| Atogepant (AGN-241689, MK-8031) | Phase III clinical trials (prophylactic treatment) |
| BI 44370 | Development terminated |
| MK-3207 | Development terminated |
| Olcegepant (BIBN4096BS) | Development terminated |
| Rimegepant (BMS-927711, BHV3000) | Phase III clinical trials (acute treatment); phase II clinical trials (prophylactic treatment) |
| Telcagepant (MK-0974) | Development terminated |
| Ubrogepant (MK-1602) | Phase III clinical trials (acute treatment) |
